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A versatile prion replication assay in organotypic brain slices
Abstract
Methods enabling prion replication ex vivo are important for advancing prion studies. However, few
such technologies exist, and many prion strains are not amenable to them. Here we describe a prion
organotypic slice culture assay (POSCA) that allows prion amplification and titration ex vivo under
conditions that closely resemble intracerebral infection. Thirty-five days after contact with prions,
mouse cerebellar slices had amplified the abnormal isoform of prion protein, PrP(Sc), >10(5)-fold. This
is quantitatively similar to amplification in vivo, but fivefold faster. PrP(Sc) accumulated predominantly
in the molecular layer, as in infected mice. The POSCA detected replication of prion strains from
disparate sources, including bovines and ovines, with variable detection efficiency. Pharmacogenetic
ablation of microglia from POSCA slices led to a 15-fold increase in prion titers and PrP(Sc)
concentrations over those in microglia-containing slices, as well as an increase in susceptibility to
infection. This suggests that the extensive microglial activation accompanying prion diseases represents
an efficacious defensive reaction.
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Methods enabling prion replication ex vivo are important for advancing prion science. 
However, few such technologies exist and many prion strains are intractable with 
them. Here we describe a prion organotypic slice culture assay (POSCA) which allows 
for prion amplification and titration ex vivo under conditions that closely resemble 
intracerebral infection. Thirty-five days after contact with prions, cerebellar slices from 
wild-type mice had amplified PrPSc >105-fold. This is quantitatively similar to 
amplification in vivo, but ca. 5-fold faster. PrPSc accumulated predominantly in the 
molecular layer, similarly to infected mice. The POSCA detected replication of prion 
strains from disparate sources, including bovines and ovines. Pharmacogenetic 
ablation of microglia from POSCA slices led to a 15-fold increase in prion titers and 
PrPSc concentration, as well as a 10-fold increase in susceptibility of slices to 
infection. This suggests that the extensive microglial activation and proliferation 
accompanying prion diseases represent a defensive reaction that significantly 







Transmissible spongiform encephalopathies (TSEs) are fatal neurodegenerative 
diseases of the central nervous system1. Their defining trait is transmissibility between 
individuals and often across species. The infectious agent causing TSEs is the prion, which 
may be identical to PrPSc, a partially protease-resistant isoform of a GPI-linked membrane 
glycoprotein termed PrPC. Mice devoid of the Prnp gene, which encodes PrPC, resist prion 
infections2.  
The most commonly used technique for measuring prions consists of inoculating test 
materials intracerebrally into susceptible “indicator” animals. Precise determinations require 
end-point dilutions with very large numbers of indicator animals. The incubation time of prion 
infections is negatively correlated to the size of the inoculum, allowing for a simplified 
incubation-time bioassay which sacrifices precision, yet requires much fewer animals3. Since 
small amounts of infectivity go along with exceedingly long incubation times, these assays 
require observation periods spanning the entire natural life of indicator animals. This is 
impractical and very expensive. In addition, minimizing the numbers of animals used for 
titration would reduce the suffering wrought by experimental prion infections. 
The introduction of the scrapie cell assay in end-point format (SCEPA) has eliminated 
some of the concerns listed above, and has allowed for a dramatic acceleration of infectivity 
assays4. Here, cells are exposed to end-point titrations of prions and are subsequently 
passaged several times. Prion titers are determined by counting PrPSc-positive tissue culture 
wells. Although the SCEPA does not require inoculation of animals, it is biologically 
equivalent to animal bioassays in that it detects actual transfer of prion infectivity from test 
materials to susceptible cells. However, the SCEPA suffers from two major limitations. Firstly, 
the infection of cultured cells reproduces only certain aspects of the in vivo situation. The 
reactions of the central nervous system (CNS) to prion infection include a concert of highly 
diverse cell types such as neurons, astrocytes, oligodendrocytes, and microglia. This 
diversity cannot be reproduced in the SCEPA, which is based on monoclonal, highly 
homogeneous cells. Secondly, the spectrum of cell lines that have been identified as 
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susceptible to prion infection in vitro is limited5. This presently restricts the applicability of the 
SCEPA to a small subset of mouse-adapted prion strains. These two limitations may be 
interdependent, since the molecular machinery necessary for overcoming strain and species 
barriers may require actions by cells distinct from those that replicate prions. Be as it may, 
any infectivity titrations of prion variants that do not efficiently infect cultured cells still require 
animal bioassays.  
Here we have investigated whether ex vivo cultures of tissues derived from wild-type or 
from genetically modified mice might help circumventing some of the above limitations. We 
found that chronically cultured organotypic cerebellar slices efficiently and rapidly amplify 
PrPSc after exposure to prions. This paradigm allows for dissecting CNS pathologies in a 
complex cellular environment morphologically very similar to the intact brain. The sensitivity 
of the prion organotypic slice culture assay (POSCA) was marginally lower than that of the 
SCEPA. While the POSCA makes use of animals as the original tissue donors, many 
genetically identical slices can be produced from each individual mouse. Hence genetic 
background variation – which is likely to account for some of the variability of mouse 
bioassays – can be controlled by comparing samples prepared from one and the same 
individual mouse. 
Activation of microglia in prion infections is very extensive and precedes significant 
neurodegeneration6, 7. Microglia are abundantly associated with prion plaques, and PrPSc can 
sometimes be found within microglia6, 8. However, it is unclear whether microglial activation 
represents a precipitating cofactor, or rather a defensive reaction. The POSCA is ideally 
suited to studying these questions. We found that complete microglial ablation from slices 
from CD11b-HSVTK transgenic mice led to a dramatic increase in prion titers and PrPSc 
deposition. These data suggest that microglia plays a significant role in containing prion 
loads during the course of prion infections.  
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Results 
Longevity of mouse cerebellar slices in long-term cultures  
As prion infections are extremely slow processes in vivo, we reasoned that successful slice 
infection would crucially depend on the establishment of organotypic cultures with the 
greatest possible longevity. Various culturing parameters were tested, including the age of 
mice used for preparing slices, the method of slice preparation, culture medium 
compositions, as well as the volume and frequency of media changing (data not shown). The 
best results were consistently achieved when slices were prepared by vibratome sectioning 
and were cultured on Millicell-CM polytetrafluoroethylene membranes. The full volume of 
medium was exchanged three times each week.  
Slice viability was assessed after 5 weeks of culturing by morphometric quantitation of 
cells permeable to propidium iodide (PI) and by DEVDase activity assays. These assays 
measure the momentary prevalence of dead cells and the substrate turnover rate of 
executioner caspases, respectively. For control, slices were treated with staurosporine, 
which induces generalized apoptotic death of neuronal cultures. Staurosporine-induced 
damage was very extensive, as assessed in situ by counting the PI+ area within whole-
mounted slices. Both PI retention and caspase activation reached a plateau within 24 hours 
of exposure to staurosporine (Supplemental Fig. 1a-c). After 35 days in vitro, untreated slices 
showed 0.1±0.02% of the PI+ cells (or <0.1±0.02% of the total tissue surface area) and 
2.1±0.6% of the DEVDase activity levels seen in staurosporine-treated slices. We conclude 
that acceptable slice viability was maintained during a period of up to 5 weeks. Morphological 
and immunohistochemical analyses with various markers of CNS constituents 
(Supplementary Fig. 1d-h) supported the latter contention.  
 
Establishment of the prion organotypic slice culture assay (POSCA). 
The most broadly used assays for assessing the presence of prion infections rely on 
the differential susceptibility of PrPC and PrPSc to digestion with proteinase K (PK)9. The 
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relative resistance of PrPSc to PK depends on the prion strain examined as well as the 
composition and concentration of non-PrP contaminants within the samples. We therefore 
determined the minimal conditions under which all PrPC present in slices would be fully 
degraded by PK. Protein lysates prepared from 5-week old slices were subjected to digestion 
with various concentrations of PK, and their PrPC content was probed by western blotting 
(Supplementary Fig. 2). Digestion of 20 μg protein lysate with 25 μg/ml PK (in a reaction 
volume of 20 μl, corresponding to 1 mg/ml total protein) was found to ensure complete, 
reproducible removal of PrPC. These conditions were used in all subsequent experiments. 
We then inoculated 3-day old pups in vivo with a relatively large inoculum 
intracerebellarly (3 μl, 1% RML) using a Hamilton syringe. Cultures were prepared from 
inoculated pups at 9 days post inoculation (dpi). Slices were cultured for 35 days in vitro, 
harvested, and assayed for PrPSc. No PK-resistant material was detected in any of 6 
inoculated animals (supplementary Fig. 3). This outcome is consistent with multiple reports 
that prions undergo a long period of eclipse after intracerebral challenge, during which no 
infectivity can be recovered from the site of inoculation. We conclude that prion infection 
before explanting the tissues is not an efficient way to achieve prion replication in culture.  
Next, we prepared organotypic slice cultures from 10-day old tga20TK pups that 
overexpress PrPC (F1 offspring of homozygous tga20+/+ males crossed to CD11b-HSVTK 
females10), or from Prnpo/o pups{Büeler et al., Nature 1992}. Groups of 10 slices were 
incubated with 1 ml of medium containing 20 mg of “RML” inoculum, which consists of crude 
brain homogenate from pooled, terminally sick CD-1 mice infected with sixth-passage RML 
prions. In order to minimize any potential toxicity stemming from cellular debris, exposure to 
RML inoculum was carried out for 1 h at 4°C in the presence of kynurenic acid, a glutamate 
receptor antagonist.  
After 5 weeks in vitro, slices were harvested, lysed, and 20 µg of protein were analyzed 
by western blotting (Fig. 1a). Detection of PrP was always carried out with monoclonal 
antibody POM1{Polymenidou, Lancet Neurology}. In order to facilitate comparisons, 20 µg 
protein from one and the same terminally scrapie-sick C57BL/6 mouse brain was loaded 
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onto the first lane of each blot (labeled as “Sc”). In lysates of tga20TK cultures infected with 
RML, a characteristic triplet band pattern representing di-, mono- and un-glycosylated forms 
of PrPSc was observed (marked by arrows) after treatment with 25 or 50 μg/ml PK (Fig. 1a, 
lanes 3, 8, 12). RML-exposed slices from Prnpo/o mice, as well as slices exposed to 
uninfected brain homogenate (Ø), never showed any PK-resistant material (Fig. 1a, lanes 
6,7,9-11,13-15).  
 
Operating characteristics and performance of the POSCA  
We examined the possibility that the PK-resistant PrP signal observed in POSCA slices 
might partly represent residual inoculum adhering to slices. We therefore performed titration 
experiments using varying amounts of inoculum for the infection of slices. PrPSc was 
unambiguously detected in cultured tga20TK slices that had been exposed to as little as 1 μg 
RML homogenate per 10 slices (Fig. 1b, lane 15). The amount of PrPSc recovered after 5 
weeks was ≥40 times higher than the total amount of inoculum used to infect the cultures 
(supplementary Fig. 4). Hence all PrP signals resulted from bona fide slice infection and de 
novo PrPSc amplification within slices. In RML-treated Prnpo/o cultures (n = 5), or in cultures 
treated with uninfected brain homogenates (n = 5), no PK-resistant material was observed 
even when the slices were exposed to 10 mg of RML inoculum (Fig. 1b, lane 4-6), indicating 
that PrPSc was amplified at least 104-fold in tga20TK slices.  
Slices infected with small amounts of RML displayed less PrPSc than those that had 
been infected with larger amounts (Fig. 1b, lane 13-15). This variability cannot be explained 
by variations in PrPC expression (Supplementary Fig. 5a). Instead, the correlation between 
the size of the inoculum and the recovery of PrPSc suggests that the accumulation of PrPSc 
was growing exponentially at the time of analysis. This is analogous to the kinetics of prion 
replication in brains of prion-infected animals, but different from lymphoreticular prion 
accumulation which typically reaches a plateau during early pathogenesis.  
In order to examine PrPSc amplification within slices in more detail, a time-course 
experiment was performed. Pools of 10 slices were inoculated with 100 μg RML (Fig. 1c). 
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Already 1 hr post inoculation no residual inoculum was detected (Fig. 1c, lanes 4-5), and no 
indication of prion replication was observed 14 days post inoculation. Only after 21 days 
could a definite PrPSc signal be observed (Fig. 1c, lane 10). PrPC expression was similar in all 
cultures (Supplementary Fig. 5b). 
We then examined the impact of host PrPC expression levels onto prion replication. We 
infected cultures from homozygous tga20TK mice (i.e. carrying two tga20 transgenic alleles), 
heterozygous Prnp+/o mice, or heterozygous tga20+ mice, and compared PrPSc levels after 
inoculating the respective slices with 1 mg RML. We observed a positive correlation between 
host expression of PrPC (tga20TK > tga20+ > Prnp+/o; supplementary Fig. 5c) and the amount 
of PrPSc observed in the cultures 5 weeks post inoculation (tga20TK > tga20+ > Prnp+/o; Fig. 
1d), analogously to what was observed upon intracerebral inoculation of mice{Büeler, 1994 
#6256}. 
 
Amplification of infectivity in organotypic cultures 
We then tested whether deposition of PrPSc goes along with prion replication, defined as a 
measurable increase in prion infectivity. Samples derived at 1, 7, 14, 28, and 35 days post-
inoculation (Fig. 1c) were used to infect the PK1 subclone4 of N2a neuroblastoma cells. 
Tga20TK slice culture homogenates showed no infectivity when assayed at <28 days after 
exposure to RML. However, slices assayed at 28 and 35 days contained >6.8 log TCI50 
(tissue culture infectivity) units/g protein of prion infectivity (1 TCI50 unit being the infectious 
dose required for infecting 50% of PK1 culture wells) as determined by the method of 
Kloehn4 (Fig. 1e). No infectivity was detected in RML-exposed Prnpo/o slice culture lysates at 
any time point. We compared the amount of infectivity in POSCA slices to a calibration curve 
of RML (Fig. 1e). RML contained >6.8 log TCI50 units/g protein (1 g RML homogenate 
contained 138 mg protein), similar to the amount of infectivity measured in RML infected 
slices. Therefore both PrPSc and prions were amplified in slices to levels similar to those 
detected in terminally sick mouse brains.  
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Sensitivity of POSCA and comparison to other assays 
To determine the infectious dose required for infecting 50% of the slice cultures, we 
performed an endpoint dilution of RML. Slices infected with 1 μg RML contains very little 
PrPSc (Fig. 1b), so 1 and 0.1 μg RML were transmitted to different groups of 10 slices on 
separate days. All cultures infected with 1 μg RML showed PK-resistant PrPSc, whereas no 
PK-resistant material was observed in cultures infected with 0.1 μg RML (Table 1, 
supplementary Fig. 6, and data not shown). The dose at which 50% of the cultures were 
infected (slice culture infectivity; SCI50) was determined and 1 ml of 10% RML (100 mg 
homogenate) contain >5.7 log SCI50 calculated according to the Kärber method11. 
Accordingly, 1 g brain yielded 6.7±0.1 log SCI50.  
In order to compare the sensitivity of the POSCA with that of other bioassays, we 
titrated dilution series of RML homogenate by endpoint dilution and intracerebral inoculation 
into tga20 and CD-1 mice, or by SCEPA (Table 1). The tga20 bioassay measured 9.9±0.2 
log ID50 units and CD-1 mice 9.3±0.9 log ID50 units/g brain homogenate. In comparison, the 
SCEPA showed a sensitivity of 7.7±0.5 log ID50/g (Table 1). 
 
Prion infection of slices does not induced obvious pathology 
We then evaluated the impact of prion infection on slice morphology. We assessed the 
morphological integrity of slices by standard light microscopy and immunohistochemistry at 
1, 7, 21 and 35 days post inoculation. Neurons (calbindin), astrocytes (GFAP) and myelin 
(MBP) appeared intact. However, broadening of cell layers became evident 7-35 days after 
culture preparation (Supplementary Fig. 1d-f). Isolectin-B4 (IB4) and CD68+ 
microglia/macrophages increased over time, confirming slices underwent progressive 
microgliosis (Supplementary Fig. 1g-h). However, no difference in any of the above 
parameters was detected between RML-treated Prnpo/o, RML-treated tga20TK or tga20TK slice 
cultures treated with uninfected brain homogenates at any given time point (Supplementary 
Fig. 1d-h; data not shown). 
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Having validated PI as a suitable cell death marker in our cultures, we evaluated PI 
retention after 5 weeks of prion infection. Surprisingly, prion infection did not exert any 
significant effect on viability (one-way ANOVA with Bonferroni’s multiple comparison test, 
p>0.05, n = 12; Fig. 2a-b). The locales of PrPSc replication/deposition were evaluated using 
the histoblot technique12. Proteins were transferred from slice cultures to nitrocellulose 
membranes by pressing the tissue onto membranes soaked in lysis buffer. After protein 
transfer, membranes were digested with 50 μg/ml PK for 30 min at 37 °C. PrPSc was 
detected by immunoblotting (Fig. 2c). A strong PrPSc signal was observed in the molecular 
layer and in the Purkinje cell layers, suggesting significant PrPSc deposition in granule cell 
axons, in Purkinje neurons and possibly in astrocytes. An intermediate signal was observed 
in the granule cell layer, and a weak signal was present in the white matter (Fig. 2c). 
 
The POSCA is applicable to a broad range of prion strains 
Theoretically the POSCA should be applicable to a much broader range of prion strains than 
the current versions of the SCEPA. We tested this prediction by exposing POSCA slices to a 
variety of murine-adapted prion strains originally derived from scrapie-infected sheep, from 
cows infected with Bovine Spongiform Encephalopathy (BSE) or from deer infected with 
Chronic Wasting Disease (CWD) (see supplementary Table 1 for details of all strains 
utilized). Slices from tga20+/+ pups were treated with homogenates of the two mouse-adapted 
scrapie strains, 79A and 139A (100 μg brain homogenate per 10 slices), we have determined 
to replicate in PK1 cells (data not shown). Infection of the tissue with either 79A or 139A led 
to an abundant accumulation of PrPSc in the tissue 5 weeks post inoculation, the extent of 
which was comparable to, or even higher than that seen in RML-exposed slices (Fig. 3a, 
lane 11-13). Two other much less chronically adapted scrapie isolates 5193/1 and 5192/2  
(brain homogenates from a terminally scrapie sick sheep from a Colorado flock passaged 
twice in tga20 or wt mice respectively, a gift by C.J. Sigurdson) also replicated in tga20+/+ 
slices, but showed less abundant PrPSc accumulation after 5 weeks (Fig. 3b, lane 14-15). 
The mouse-adapted BSE strain 301C replicated in tga20+/+ slices (Fig. 3b, lane 12). PK1 
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cells are known to be resistant to an infection with the mouse adapted scrapie strain, ME74. 
In slices derived from tga20+/+ pups infected with ME7 (100 μg), a faint PrPSc signal could be 
found 5 weeks post inoculation (Fig. 3b, lane 13). We infected slices with an increased 
amount of ME7 (1 mg) and after 5 weeks a clear PrPSc signal was found in all ME7-treated 
tga20+/+ cultures (Fig. 3c, lane 13-15), showing that POSCA exhibit a broad specificity.  
However, not all strains tested positive in the POSCA after 5 weeks. Four murine-adapted 
scrapie strains; 87A, 87V, 22F, and 301V, failed to infect slice cultures 5 week post 
inoculation (100 μg brain homogenate per 10 slices; Supplementary Fig. 6 and data not 
shown). All of these strains exhibited long incubation times after intracerebral inoculation of 
30 μl 10% brain homogenate into C57BL/6 mice (>280 days, Supplementary table 1). In 
comparison, all strains that replicate in POSCA showed incubation times between 150-200 
days (RML, 79A, 139A, ME7, 5193/1 and 301C; Supplementary table 1). The only exception 
was 5192/2 that showed an incubation time of 270 days (Supplementary table 1). Therefore, 
the capability of various strains to induce disease upon intracerebral inoculation into C57BL/6 
mice correlates well with their replication in the POSCA. 
We also tested a strain of mouse-adapted CWD from a Colorado mule-deer flock13. Tga20 
mice inoculated intracerebrally with brain homogenate of a terminally sick mule-deer (30 μl, 
10% homogenate) developed disease 400 days post inoculation upon 1st passage (5002), 
228 days post inoculation upon 2nd passage (5005) and 138 days post inoculation upon 4th 
passage (5194). Groups of 10 slices were exposed to 100 μg of tga20 brain homogenate 
from each of the passages described above. However, this murine-adapted CWD inoculum 
did not appear to replicate in tga20 slices 5 weeks post inoculation (data not shown). 
 
Conditional microglia depletion in organotypic slice cultures 
We had previously generated CD11b-HSVTK mice, which allow for conditionally ablating 
microglia in vivo and in vitro with the cytotoxic prodrug ganciclovir (GCV)10. We prepared 
organotypic cerebellar slices derived from 10-day old CD11b-HSVTK mice, and added GCV 
(5 μg/ml) to the medium. After 14 days, GCV treatment led to an almost complete loss of IB4+ 
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and CD68+ cells in CD11b-HSVTK+ slices (tk+), but not in CD11b-HSVTK- slices (tk-) (Fig. 4a-
b). The few remaining IB4+ cells appeared fragmented or associated to IB4+ blood vessels 
(Fig. 4a). Time-lapse microscopy performed on IB4-labelled GCV-treated tk+ slices after 9-14 
days of culture revealed that many microglial cells undergo cell death upon engulfment by 
neighboring microglia, suggesting apoptosis (supplementary Video 1). As cells were 
undergoing apoptotic changes, other viable neighboring microglia took up the dying cells. 
These phagocytes, in turn, underwent apoptosis and were removed by other microglia until 
most microglia were gone, eventually leaving only few microglia in the tissue.  
Microglia depletion was quantified from images acquired by confocal laser scanning 
microscopy at a depth of 35-40 μm (i.e. underneath the glial scar). Tk+ slices showed a 
reduction in microglia of 97%, 98% and 99% after 14, 28, and 42 days of GCV treatment, 
respectively (one-way ANOVA with Bonferroni’s multiple comparison test, p<0.001, n = 4; 
Fig. 4c). Very few if any microglia were found outside the tissue in treated tk+ slices (Fig. 4d). 
Quantification of mRNA transcript levels by quantitative RT-PCR showed a 98% reduction in 
CD11b expression in tk+ slices treated with GCV for 14 days (p<0.001, n = 3), whereas 
GFAP, MBP and neurofilament heavy-chain transcripts (markers for astrocytes, 
oligodendrocytes and neurons respectively) were unaffected (one-way ANOVA with 
Bonferroni’s multiple comparison test, p>0.05) (Fig. 4e). Importantly, GCV treatment had no 
effect on tk- slices (Fig. 4e). GFAP protein expression increased over time and multiple 
lower-running isoforms could be observed after 7-21 days in culture (Fig. 4f). Depletion of 
microglia did not affect GFAP expression, suggesting that the astrogliosis induced by 
preparing and culturing the slices was independent of microglia activation. The concentration 
of PrPC was unaltered in microglia-depleted slices (Fig. 4g). 
 
Lack of ‘bystander killing’ after microglia depletion 
Phosphorylated GCV released from dying microglia may be taken up by neighboring cells 
and cause bystander toxicity. The viability of CD11b-HSVTK+ slices treated with GCV for 14 
days was assessed with respect to PI incorporation and DEVDase activity. Microglia-
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depleted slice cultures displayed a small but significant increase in PI+ cells from 
approximately 1% up to 2% of the total surface area (One-way ANOVA with Bonferroni’s 
multiple comparison test, p<0.001, n = 12) (Fig. 4h). No difference in caspase activity was 
observed (n = 3 pools of 4 slices) (Fig. 4h).  
To evaluate if the increase in cell death could be due to impaired corpse removal, we 
reconstituted microglia-depleted slices with peritoneal wt macrophages, which are resistant 
to GCV. Macrophages were either placed directly onto the slices, or were separated from 
them through Millicell-CM membranes. Direct reconstitution of slices with wt peritoneal 
macrophages (macrophages placed onto slices) partially rescued the GCV-induced increase 
in PI+ cells, suggesting a decrease in the removal of dead cells within the tissue 
(Supplementary Fig. 7). We speculated that the increased PI+ cells might represent 
dying/dead tk+ microglia. To test this, we performed dual-labelling of unfixed GCV-treated 
CD11b-HSVTK slices with PI and IB4. In GCV-treated slices most PI+ cells were co-stained 
with IB4, indicating that the increase in PI+ cells was indeed due to dead microglia (Fig. 4i-j).  
Phosphorylated GCV released from dying cells cannot only cause bystander cell death, 
but also cell-cycle arrest14. To sensitively test for adverse GCV-mediated effects, we assayed 
BrdU incorporation into the DNA of dividing cells. GCV treatment of tk+ slices for 14 days 
abolished BrdU+/CD68+ cells as expected, whereas the number of Brdu+/CD68- cells (non-
microglia BrdU+ cells characterized by a large nuclei) was unaffected (Fig. 4k-l). Also, GCV 
treatment of tk- slices had no significant effect on BrdU incorporation. Therefore, depletion of 
CD68+ cells is selective and transgene-dependent, and does not elicit any significant 
bystander effects.  
 
Microglia depletion dramatically affects prion replication 
To address the contribution of microglia to prion replication, we prepared slices from tga20TK 
CD11b-HSVTK- (tga20TK-) and tga20TK CD11b-HSVTK+ pups (tga20TK+). Tga20TK+ and 
tga20TK- slices infected with RML (100 μg RML, i.e. 2.7 log SCI50), were split into two pools, 
one of which was treated with GCV. After 30 days, similar amounts of PrPSc were observed 
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in untreated tga20TK+ and in both untreated and GCV-treated tga20TK- slices. Interestingly, 
microglia depletion by GCV treatment of tga20TK+ slices resulted in a 5-fold increase in PK-
resistant PrPSc (Fig. 5a). Since this increase was independent of PrPC expression 
(Supplementary Fig. 8a), microglia either directly affected the conversion of PrPC into PrPSc 
or – more likely – affected the half-life of PrPSc by phagocytosing and degrading prions. To 
test whether the observed increase in PrPSc was associated only with microglial expression 
of HSVTK we infected slices prepared from 10-day old GFAP-HSVTK mice (gfapTK) that 
allows for conditional ablation of astrocytes15. In contrast to CD11b-HSVTK+ cultures, GCV-
treatment of GFAP-HSVTK+ (gfapTK+) cultures had no major impact on PrPSc or PrPC (Fig. 5c, 
Supplementary Fig. 8b). Hence increased PrPSc levels are selectively associated with 
microglia depletion.  
To further study whether the observed effect was due to GCV-mediated removal of 
microglia, we tested whether the enhanced accumulation of PrPSc could be counteracted by 
reconstituting the macrophage population. After exposure to the RML inoculum (2.7 log 
SCI50), tga20TK+ and Prnpo/o/TK+ were separated into 4 pools each and 3 pools/condition were 
treated with GCV to deplete microglia. 250,000 tga20 or Prnpo/o macrophages (labeled as 
tga20Ф and Prnpo/oФ, respectively) were added to two GCV-treated cultures and 30 days 
post inoculation the tissues were harvested and analyzed. Microglia-depleted tissue was 
reconstituted at the time of infection with peritoneal macrophages from Prnpo/o and tga20+/+ 
mice, respectively. After microglia depletion a clear increase in PrPSc was observed as 
expected (Fig. 5c). This increase in PrPSc could be reduced upon reconstituting slices with 
macrophages, irrespectively of whether the macrophages expressed PrPC (Fig. 5c). Microglia 
depletion/reconstitution was verified by analyzing the expression levels of the macrophage 
marker Iba1 (Fig. 5e). PrPC levels were equal in all samples (Fig. 5d) and no differences in 
caspase activity (Fig. 5g) or GFAP expression (Fig. 5f) were observed in either of the prion 
infected tissues.  
Next, we used SCEPA to analyze tga20TK+ samples, untreated or treated with GCV for 
30 days from three independent biological experiments performed on different days. 
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Microglia-depleted cultures showed a significant 14.5±13.2 fold increase over non-depleted 
cultures in their prion titers (one-tailed paired student T-test, p = 0.474, n = 3)(Fig. 5h), which 
corresponds very well to the difference observed by western blot analysis of microglia-
depleted samples (a 9±11.8 fold increase over non-depleted slices, n = 6). Despite a high 
inter-experimental variance, all six independent replicas displayed a clear increase in PrPSc 
accumulation after microglia-depletion (2-33 fold). No residual inoculum was observed in 
Prnpo/o-tk+ culture irrespectively of microglia status (Fig. 5h). These results confirm that 
microglia regulate both PrPSc and prion formation in a negative fashion.  
Microglia-depleted tissue accumulates prions to a higher degree, begetting the 
question whether GCV-treated tk+ slices would be more sensitive to a prion infection. We 
therefore performed an end-point titration experiment with RML on tga20TK+ slices. Tga20TK+ 
slices were infected with various concentrations of RML and separated into two pools. One 
pool was left untreated and the other was treated with GCV. After 5 weeks in vitro, PK-
resistant material was observed in microglia-depleted tissue at a 10-fold higher RML-dilution 
(0.1 μg, i.e. -0.3 log SCI50), showing that microglia-depleted tissue indeed is more sensitive 




Analytical sensitivity of POSCA, SCEPA, and other methods.  
Measuring prions is still fraught with difficulties. As no certainty has yet been attained 
about the precise physical nature of the agent, the transmission of serially diluted test 
materials to susceptible hosts remains the undisputed gold standard. The POSCA strives to 
combine the versatility of the mouse bioassay, which can identify many different strains of 
prions and can take advantage of a large repository of genetically modified mice, with the 
speed and analytical precision of the SCEPA, which is based on continuously growing 
neuroblastoma cells4. 
How does the analytical sensitivity of the POSCA rate against other methods of prion 
titration? We have evaluated the operating characteristics of the POSCA against the two 
most commonly used prion titration assays: the SCEPA4 and the mouse endpoint bioassay16. 
The sensitivity of SCEPA was <10-fold higher than that of POSCA, the limits of detection 
being 7.7 log LD50/g brain for SCEPA, 9.9 log LD50/g for the tga20 bioassay, and  >6.7 log 
LD50/g for POSCA. Depletion of microglia led to a 10-fold increase in analytical sensitivity, 
thereby approaching the characteristics of the SCEPA. In contrast to SCEPA cultures, 
POSCA slices are exposed to infectivity for much shorter periods of time, and are washed 
extensively after inoculation. Perhaps sensitivity can be optimized by varying the exposure 
and washing steps, particularly since residual inoculum does not appear to interfere with 
POSCA readings. As prion replication may have not have reached a plateau in slices after 35 
days, sensitivity may conceivably be further enhanced by harvesting slices at later time 
points. Organotypic murine slice cultures has been reported to be viable in culture for up to 
26 weeks17.  
Some alternative cell-culture based assays have been reported. Primary cultures of 
neurons and astrocytes18 and neurospheres has been shown to be infectible in vitro19. In a 
historical comparison, the neurosphere assay measured approximately 5 log LD50/g19. In 
these culture systems, however, residual prion inoculum persisted in Prnp-deficient cultures 
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after 24-28 days. The latter is a serious hindrance to the adaptation of such systems to prion 
titrations. 
In theory, the SCEPA should be adaptable to detecting any existing prion strain by 
using appropriate cell lines. In practice, however, only few selected cell lines appear to be 
efficiently and chronically infectible with prions, and the crucial determinants of infectibility 
are unknown. Moreover, the few suitable cell lines are highly selective in their permissibility 
to various prion strains. In contrast, the transgenic expression of xenogeneic Prnp 
minigenes, particularly when including domains from different species, has significantly 
broadened the spectrum of strains measurable by mouse bioassay. This broad spectrum of 
hosts can be fully exploited by the POSCA, as organotypic brain slice cultures can be 
prepared from mice of any desired genotype. This yields a flexible and robust experimental 
system to study prion infection. Accordingly, we found that not only the chronically mouse-
adapted RML prions, but also a variety of sheep scrapie and bovine BSE strains replicate in 
slices derived from tga20+/+ pups. The collection of POSCA-compatible strains includes ME7 
prions, which do not replicate in PK1 cells4.  
We predict that the versatility of the POSCA will be increased even further by availing 
of specific mouse lines susceptible to human, bovine, ovine, and cervid prions. This may help 
clarifying the molecular basis of strain adaptation20 by enabling a highly controlled 
environment and a compressed time frame. As a first step towards this goal, we have 
successfully infected POSCA slices with POSCA-derived inoculum (data not shown). 
Compared with its in vivo counterparts, the POSCA has a very short incubation time. 
intracerebral inoculation of tga20 mice with RML prions induces disease after 60-150 days21, 
yet we detected prion replication after 20 days in tga20TK slices (10-3 RML).  Analogously, we 
observed prion replication in Prnp+/o slices after 35 days, whereas Prnp+/o mice show 
incubation times of 225-300 days after intracerebral inoculation2. The rapid replication in 
slices suggests the existence of unidentified protective processes that are operative in vivo 
but may be disabled in slices.  
 18
Surprisingly, we did not observe any pathological changes in POSCA slices as a 
consequence of prion infection. Although neuronal death and astrogliosis are among the 
defining morphological characteristics of prion-infected brains, we saw no significant changes 
in slice viability and in astrogliosis (as measured by GFAP expression). It is unlikely that any 
developing pathology was masked by continuous removal of dead cells by microglia, since 
there was no difference between microglia-depleted and non-depleted prion-infected slices 
(Fig. 5g). Instead, it is more likely that the considerable distortions resulting from slice 
isolation and culture, including significant astrogliosis (Fig. 4f), microgliosis, neuronal death, 
and formation of glial scars, may mask any additional prion-induced pathology. Inasmuch as 
the relevant neuroectodermal cell types are preserved, we do not view these changes as 
limiting for the deployment of POSCA.  
 
Microglia in prion disease 
Microglia activation is an early, extensive hallmark of most prion diseases, yet it is 
unclear whether microglial proliferation is good or bad for the prion-infected brain. Many 
studies point to potentially deleterious effects of microglia. Firstly, microglia can release 
inflammatory and neurotoxic factors typically associated with neurodegenerative diseases22-
24. Secondly, microglial cells are often spatially associated with prion plaques, and infectivity 
was recovered from microglia purified from terminally sick mice6, 8, 25, leading to the 
conjecture that microglia acts as a carrier of prions within the brain. This scenario predicts 
that microglia might play a detrimental role at several levels, but cannot be easily reconciled 
with the observation that peripheral macrophages can reduce prion infectivity in vitro and 
splenic PrPSc accumulation in vivo26-28. In addition, Prnp+/+ microglia do not support prion 
replication when grafted into Prnpo/o brains29.  
Selective manipulation of microglial cells in vivo is hampered by their similarities to 
macrophages. Also, many microglial/macrophage markers are coexpressed by 
hematopoietic stem cells, thereby limiting the feasibility of ablation strategies. Since 
hematopoiesis is irrelevant to brain slices, the POSCA is well suited to studying the impact of 
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microglial manipulations onto prion replication. We found that microglia can be completely 
ablated by treating CD11b-HSVTK+ cerebellar slice cultures10 with GCV without affecting the 
viability of other cell populations. The administration of GCV appeared to encourage 
microglia’s instincts: time-lapse microscopy (supplementary video) revealed a striking 
landscape of widespread suicide, fratricide, and cannibalism of microglia at the hand of 
fellow microglia. On the other hand, we found that microglia removal drastically unleashes 
prion replication in organotypic slices. This observation points to a role for microglia in 
containment of prion infections. Microglia may exert this role by phagocytosing and 
degrading prions in situ26-29, possibly explaining the presence of prions in microglia acutely 
isolated from scrapie-sick mice25 despite its inability to replicate prions29.  
There may be eminently practical ramifications to the phenomena described above. 
One ID50 unit of prions measured upon intracerebral challenge has been reported to be 
equivalent to 104-105 PrP molecules30. This is in sharp contrast to many viral diseases in 
which 1-10 particles are equivalent to one ID50, and has been taken to cast doubts on the 
identity of the prion with PrPSc31. The priolytic activity of microglia uncovered in the present 
study may contribute to increasing the minimal amount of PrPSc needed to infect individual 
organisms. By extension, one might speculate that medical conditions and iatrogenic 




Culture preparation and prion inoculation. All mouse experiments were performed 
according to Swiss federal regulations. The pups used for most experiments were F1 
offspring of tga20+/+ Prnpo/o males on a 129Sv/BL6 background crossed to heterozygous 
CD11b-HSVTK females (tg620) on a C57BL/6 background10. We refer to the Prnp+/o tga20+ 
HSVTK transgene-negative offspring as tga20TK- and the transgene-positive littermates as 
tga20TK+. Prnpo/o, Prnp+/o and Prnpo/o tga20+ mice were all on a 129Sv/BL6 background. 
CD11b-HSVTK (tg620) and GFAP-HSVTK mice (line 7.1) were all on a C57BL/6 background 
and were genotyped as previously described10, 32. Rocky Mountain Laboratory strain 
passage-6 (RML) was amplified in CD-1 mice, ME7 in 129/Sv mice, 5193/1 in tga20 mice 
and 22F, 79A, 87A, 87V, 139V, 301V, 5192/2 and 301C (murine-adapted BSE) were all 
amplified in C57BL/6 mice by intracerebral inoculation of 30 μl 10% brain homogenate. 
Organotypic cerebellar slice cultures were prepared according to a modified version of a 
protocol by Stoppini et al.33. In brief, the cerebellum was obtained from 9-12 day old pups. 
Brain tissue was embedded in 5 ml liquid  (2% w/v) Ultra-low melting point agarose dissolved 
in Gey’s balanced salt solution (GBSS) (NaCl 8 g/l, KCl 0.37 g/l, Na2HPO4 0.12 g/l, 
CaCl2·2H20 0.22 g/l, KH2PO4 0.09 g/l, MgSO4·7H20 0.07 g/l, MgCl2·6H20 0.210 g/l, NaHCO3 
0.227 g/l) supplemented with the glutamate receptor antagonist kynurenic acid (1 mM) 
(GBSS-K). Liquid agarose (kept at 37 °C using a water bath), was transferred to a small 
container, the isolated brain tissue was submerged and cooled on ice until the agarose 
solidified (10 min). The agarose block was mounted onto a specimen disc and 350 μm thick 
slices were cut on a vibratome (VT1000, Leica-microsystems) while submerged in a cooled 
reservoir (4 °C) containing GBSS-K. Slices were recovered from the agarose and transferred 
in a small volume of liquid to a 24-well plate using a Pasteur pipette (using the broad end of 
the pipette). Cultures were treated with various concentrations of prion-infected or uninfected 
brain homogenates (homogenized in PBS) diluted in 1 ml GBSS-K. Tissues were incubated 
with brain homogenates as free-floating sections for 1 h at 4 ºC. Slices were washed twice by 
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transferring the slices in a small volume (approximately 0.5 ml) to a reservoir containing 6 ml 
fresh GBSS-K and 5-10 slices were placed on a 6-well Millicell-CM BioporeTM PTFE 
membrane insert (Millipore). Residual GBSS was removed and the inserts were transferred 
to a cell culture plate and cultured for up to 5 weeks in slice culture medium (50% MEM, 25% 
BME and 25% horse serum supplemented with 0.65% glucose (w/v), penicillin/streptomycin 
(1x) and Glutamax (1x) (Invitrogen). Cultures were kept in a standard cell incubator (37 °C, 
5% CO2 and 95% humidity) and 80% of the culture medium was exchanged three times a 
week. 
For reconstitution experiments, peritoneal macrophages were obtained. Mice were 
euthanized and the abdominal skin was removed without disturbing the peritoneal cavity. 5 
ml ice-cold PBS was injected into the peritoneal cavity using a 25-gauge needle. After 
massaging the abdomen macrophages were recovered and cells were counted using 0.4% 
Trypan blue. OCSCs were reconstituted at the time of preparation at a density of 250,000 
macrophages/insert (10 slices/6-well insert) and GCV-treatment was initiated immediately. 
GCV was used at a concentration of 5 μg/ml, a concentration previously shown to be optimal 
for microglia depletion in vitro10. 
Western blot analyses. Cultures were washed twice in PBS, residual PBS was 
removed and the tissue was scraped off the membrane using 10 μl lysis buffer per slice 
(0.5% sodium deoxycholate and 0.5% Nonidet P-40 in PBS). Tissue was lysed by three 
freeze-thaw cycles and triturated using a 200 μl pipette until homogeneous. For SCEPA 
analysis, Slices were harvested by scraping the tissue off the membrane in PBS, triturated 
using a 29-G insulin syringe, followed by 30 sec of sonication. Each sample was a pool of 5-
10 slices grown on the same insert, yielding approximately 2-350 μg protein in total. Protein 
concentration was determined using the bicinchoninic acid assay (Pierce) and the tissue was 
digested with PK (Roche) in lysis buffer for 30 minutes at 37 °C. PK-resistant material was 
detected as a standard by digesting 20 μg protein lysate in a reaction volume of 20 μl [1 
mg/ml total protein] with 25 μg/ml PK. This condition was more sensitive as compared to 
using higher PK concentrations, but still allowed for specific detection of PrPSc. PK digestion 
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was stopped by adding loading buffer (NuPAGE, Invitrogen) and boiling the samples at 95 °C 
for 5 minutes. Proteins were separated on a 12% Bis-Tris polyacrylamide gel (NuPAGE, 
Invitrogen) and blotted onto a nitrocellulose membrane. Membranes were blocked with 5% 
Topblock (Fluka) in tris-buffered saline supplemented with tween (150 mM NaCl, 10 mM Tris-
HCl, 0.05% Tween 20 (v/v)) and incubated with primary antibodies in 1% Topblock. Primary 
antibodies used were POM1 mouse anti-PrPC IgG1 (200 ng/ml), ascites fluid of mouse anti-
Glial Fibrillary Acidic Protein (GFAP) IgG1 (Clone GA5) (1:3,000, Sigma-Aldrich) and goat 
anti-human Iba1 (0.5 μg/ml, Wako). Secondary antibodies used were horseradish 
peroxidase-conjugated (HRP) rabbit anti-mouse IgG1 (1:10,000, Zymed) and HRP-
conjugated swine anti-rabbit IgG, (260 ng/ml, DAKO). The blots were developed using 
SuperSignal® West Pico Chemiluminescent substrate (Pierce) and detected using the 
VersaDoc system (model 3000, Biorad). The molecular weight marker was spiked with 
recombinant PrPC yielding a PrP-signal at 23 kDa, with a degradation product at 15 kDa. 10 
μl marker were loaded in the left lane on all blots. 
Cell death measurements. PI incorporation was measured by incubating the slices 
with propidium iodide (PI) (10 μg/ml, Molecular Probes) for 15 minutes. Images were 
acquired using a fluorescent microscope (Axiovert 200M equipped with Axiocam HRm, 
Zeiss) and images were analyzed using image analysis software analySIS© vs5.0 (Olympus 
Soft Imaging Solutions GmbH, Münster, Germany). All images were acquired using the same 
exposure times and analyzed using the same software settings within a region of interest 
(the total area of tissue present in the image). After recording fluorescent images, the tissue 
was washed in PBS and lysed in PBS, 0.5% Nonidet-P40, 0.5% DOC and 5 mM 1,4-
dithiothreitol. Caspase-3 Fluorometric Correlate-Assay (Assay designs) was used to 
determine caspase-3 DEVDase activity according to the manufacturers instruction. In brief, 
protein lysates were incubated with the fluorogenic caspase-3 substrate, Ac-DEVD-7-Amino-
4-methyl coumarin, and enzymatic cleavage by caspase-3 was quantified by kinetic 
measurements (1 measurement every two minutes for two hours) using a fluorometer. The 
specific caspase activity was calculated from a standard curve generated using recombinant 
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caspase-3 with a known enzymatic activity and normalized to the protein content. One unit of 
caspase-3 activity is defined as the amount of enzyme needed to convert one picomol of 
substrate per minute at 30 ºC. 
Immunocytochemistry. Histoblot analysis was performed according to a standard 
protocol using 50 μg/ml PK (30 min., 37 °C)12. For immunocytochemistry the tissue was fixed 
in 2% PFA, o/n at 4 °C. Membrane inserts were washed and incubated for 1 h in blocking 
buffer (0.1% Triton X-100 and 2% goat serum dissolved in PBS) and incubated for 2 days 
with primary antibody diluted in blocking buffer. Primary antibodies and concentrations used 
were ascites fluid of anti-chicken calbindin IgG1 antibody (1:2,000, Swant), rabbit anti-mouse 
GFAP polyclonal antibody (1:1,000, DAKO), rat anti-mouse CD68 IgG2a (1 μg/ml, Serotec) or 
ascietes fluid of rat anti-bovine MBP IgG2a (1:250, Serotec). The primary antibodies were 
detected using Alexa-conjugated secondary antibodies (4 μg/ml, Molecular Probes) and 
counterstained with Dapi (1 μg/ml). Microglia were detected in fixed and in live tissue by 
staining with IB4 (Griffonia Simplicifolia) (2-4 μg/ml, Molecular Probes). The culture 
membranes were removed from the inserts and mounted directly onto a microscope slide 
using fluorescent mounting medium (DAKO). Images were acquired in a focal plane 35-40 
μm below the tissue surface using a laser-scanning confocal microscope (SP 2, Leica), by 
fluorescent microscopy (Axiovert 200M, Zeiss) or for live imaging studies by using wide-field 
microscope (DM IRBE, Leica) equipped with a temperature controller and a CO2 box (37 °C 
and 5% CO2). Incorporation of 5-bromodeoxyuridine (BrdU) into the tissue was assessed 
after 24 h incubation with 25 μg/ml BrdU. DNA was denatured by treatment with 1N HCl for 
1h at 37 °C, followed by 2 x 30 min neutralization steps with 0.1 M Borate (pH 8.5) and 2 
washes in PBS. The tissue was subsequently stained with 15 μg/ml mouse anti-
bromodeoxyuridine IgG1 (clone BU-33, Sigma) and rat anti-mouse CD68 according to normal 
procedures. Counting was performed manually, assisted by image analysis software 
analySIS© vs5.0. 
Quantitative PCR. Organotypic slice cultures were prepared and incubated as 
previously stated. Cultures were washed once with PBS and total RNA was extracted using 
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TRIzol reagent (Invitrogen Life Technologies) according to the manufacturer’s protocol. 
Before cDNA synthesis residual genomic DNA was removed using the DNA-free kit (Ambion) 
and cDNA was synthesized from 1 μg total RNA with QuantiTect reverse transcription kit 
(Qiaqen) using random hexamers according to the manufacturer’s protocol. Successful 
cDNA synthesis and contamination of total RNA with genomic DNA was tested by PCR with 
primers specific for Actb. Quantitative real-time PCR was performed using the SYBR Green 
PCR Master Mix (Applied Biosystems) on an ABI PRISM 7700 Sequence Detector 
(PerkinElmer). Fold regulation was calculated relative to untreated transgene-negative slices 
(wt) after normalization to the β-actin signal. The following primer pairs were used: Actb 
sense (NM_007393): 5’-GAC GGC CAG GTC ATC ACT AT-3’, antisense: 5’-ACA TCT GCT 
GGA AGG TGG AC-3’. Itgam sense (NM_008401): 5’-GAC TCA GTG AGC CCC ATC AT-3’, 
antisense 5’-AGATCG TCT TGG CAG ATG CT-3’. MBP (NM_010777) and Nefh 
(NM_010904) were detected using the commercially available QuantiTect primer assay 
(Qiagen). 
Scrapie cell assay in endpoint format (SCEPA): Prion-susceptible neuroblastoma 
cells (subclone N2aPK1) were exposed to brain homogenates in 96-well plates for 3 days. 
Cells were subsequently split three times 1:3 every 2 days, and three times 1:10 every 3 
days. After confluence was reached, 25,000 cells from each well were filtered onto the 
membrane of an ELISPOT plate, treated with PK (0.5 μg/ml for 90 min. at 37 °C), denatured 
and individual infected (PrPSc-positive) cells were detected by immunocytochemistry using 
alkaline phosphatase-conjugated POM1 mouse anti-PrP antibody and alkaline phosphatase 
conjugate substrate kit (Biorad). Serial ten-fold dilutions were performed in cell culture 
medium containing healthy mouse brain homogenate. Scrapie-susceptible PK1 cells were 
then exposed to dilutions of experimental samples ranging from 10-3 to 10-6, or a 10-3 dilution 
of healthy mouse brain homogenate (Ø) or RML. Samples were quantified by total 
luminescence per well or in end-point format by counting positive wells according to 
established methods4. 
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Statistical analysis: One-way ANOVA with Bonferroni posttest for selected pairs of 
columns was used for statistical analysis of experiments involving the comparison of three or 
more samples. Paired student T-test was used for comparing two samples. Results are 
displayed as the average of replicas ± standard deviation. For assay comparisons in Table 1, 
all values are given as the determined titer ± the standard error calculated within the single 
experiment (i.e. not the biological variation). 
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Table 1: Comparison of the sensitivity of four different prion infectivity assays. The assay 
sensitivity of the tga20 and CD1 bioassay, SCEPA and POSCA was compared by performing 
endpoint titrations of the same batch of RML brain homogenate in the various assays. The 
infectivity titers per g of brain were determined according to Kärber11 and expressed as TCI50 
units for the SCEPA, SCI50 for the POSCA, and LD50 for tga20 and CD1 mice. Each data 
point represents the number of infected animals or cultures out by the total number of 
animals or cultures exposed to the inoculum. SE: (standard error). The sensitivity of POSCA 
















10 -1 4/4 54 ± 1 7/7 119 ± 1 (n.d.) 5/5 
10 -2 4/4 59 ± 2 7/7 124 ± 1 6/6 5/5 
10 -3 3/3 69 ± 1 7/7 126 ± 1 6/6 15/15
10 -4 4/4 77 ± 2 6/6 132 ± 4 12/12 5/5 
10 -5 6/6 86 ± 2 5/5 135 ± 3 12/12 9/9 
10 -6 6/6 93 ± 2 5/5 159 ± 4 12/24 0/9 (2/2*)
10 -7 6/6 119 ± 4 2/5 167 ±16 5/24 0/3 
10 -8 1/6 121, >236 1/5 202, >239 0/24 
10 -9 0/5 >236 0/5 >239
log ID50/g ± SE 9.9 ± 0.2 9.3 ± 0.9 7.7 ± 0.5 >6.7 ± 0.1
tga20 CD1
*microglia-depleted slices. 
N.D.: not determined 
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Figure legends      
Figure 1: Viability and prion replication of POSCA slices. (a) PrPSc accumulation in slice 
cultures. Slices from 12-day old tga20TK and Prnpo/o mice were exposed to RML-infected (R) 
or uninfected brain homogenate (Ø), cultured for 5 weeks, optionally digested with 25 or 50 
μg/ml PK, and probed with anti-PrP antibody POM1. In all figures, sample labels indicate the 
PrPc expression levels as dictated by the genotype of the tissue donors: “o/o”, Prnpo/o; “+/-“, 
hemizygous; “+/+”, wild-type; “++” hemizygous for the tga20 allele and Prnpo/o; “+++”, 
hemizygous for the tga20 allele and Prnp+/o; “++++”, homozygous for the tga20 allele and 
Prnpo/o. Arrows identify the characteristic glycoforms of PrPSc. (b) Sensitivity of the POSCA. 
tga20TK and Prnpo/o slices were inoculated with decadal dilutions (104-1 µg) of RML-infected 
or uninfected brain homogenate, and cultured for 35 days prior to harvesting. Successful 
slice infection was brought about by as little as 1 µg homogenate. (c) Time course of PrPSc 
accumulation in infected slices. tga20TK (+) and Prnpo/o (-) slices were inoculated with 100 μg 
RML-infected or uninfected brain homogenate (Ø), and harvested at various time points (dpi: 
days post inoculation). PrPSc was first detectable after 21 days and progressively 
accumulated until 35 days without reaching a plateau. (d) Prnp gene dosage and PrPSc 
accumulation in slices. Tga20TK, tga20+, Prnp+/o or Prnpo/o slices were inoculated with 1 mg 
RML or Ø, and harvested 35 days post inoculation. (b-d) Western blots were performed on 
samples digested with PK (+), or without PK (-). (e) Time-dependent buildup of prion titers in 
slices. RML and slice homogenates from the time course experiment depicted in panel (c) 
were diluted by serial 10-fold dilutions in uninfected brain homogenate, and prion titers were 
determined by SCEPA with PK1 cells. Exposure to 10 μg or 1 μg, but not 100 ng protein/ml 
from slices cultured for ≥28 days resulted in unambiguous replication of prion infectivity in 
PK1. In agreement with the PrPSc determinations, no infectivity from any residual inoculum 
was detected as early as after 1 day of culture. Vigorous prion replication was detected in 
PK1 cells exposed to 10 µg/ml homogenate. 
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Figure 2: Localization and impact of prion replication. (a) Tga20TK and Prnpo/o cultures were 
inoculated with 100 μg RML or Ø 35 days post inoculation PI incorporation was analyzed. 
Data are presented as the average of 12 slices ± SD (b) Representative examples of images 
used for PI incorporation. (c) Tga20TK and Prnpo/o cultures were inoculated with 100 μg RML 
or Ø. 35 dpi slice culture homogenates were blotted onto nitrocellulose. The membrane was 
digested with 50 μg/ml PK and PrPSc was detected as described in materials and methods 
using the POM1 antibody.  
 
Figure 3: A broad spectrum of strains is tractable by POSCA. (a-b) Cultures were prepared 
from 10-day old tga20+/+ and Prnpo/o pups, inoculated with various prion strains as indicated 
(100 μg homogenate), and harvested after 35 days. Ø: noninfectious brain homogenate. (a) 
Transmission of murine-adapted scrapie strains RML, 139A, 79A and Ø. (b) Transmission of 
murine-adapted BSE 301C, murine adapted scrapie strains 5193/1, 5192/2, ME7, RML, and 
Ø. For comparative purposes, RML-infected slice culture samples were diluted 10-fold in 
uninfected brain homogenate prior to PK-digestion to decrease the PrPSc signal on the 
western blot (lane 10). Western blotting was performed under less stringent conditions on 60 
μg protein digested with 50 μg/ml PK (+) or 30 μg non-digested protein (-) and detected with 
mouse anti-mouse PrPC IgG1 (POM1). PrPSc was found in tga20+/+ cultures treated with RML, 
301C, 5193/1 or 5192/2, showing that the strain replicates in slices. Only a very faint signal 
was detected in the ME7-treated sample. (c) Cultures were prepared from 10-day old 
tga20+/+ and Prnpo/o pups, inoculated with 0.1 and 1 mg of RML, ME7 or Ø and cultured for 
35 days prior to harvesting the tissue. Western blotting was performed as indicated in (b). A 
clear PrPSc signal was observed in slices treated with higher amounts of ME7 (1mg).  
 
Figure 4: Microglia depletion in organotypic slice cultures. Slices from 10-day old CD11b-
HSVTK+ mice were cultured for 1, 14, 28 or 42 days (DIV) in the optional presence of GCV,  
fixed in 2% PFA, and stained with (a) IB4-Alexa488 or (b) α-CD68. The quantification of cells 
resident within (c), or migrating out of, slices (d) revealed a complete loss of IB4+ cells within 
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14 days of GCV treatment. (e) CD11b-HSVTK+ (tk+) and CD11b-HSVTK- (tk-) slices were 
cultured for 14 days in presence or absence of GCV. Whereas the abundance of neuron 
(Neurofilament), astrocyte (GFAP), and oligodendrocyte-specific (MBP) transcripts were 
unaffected, transcription of the microglia-specific CD11b gene was dramatically reduced (n = 
3). (f-g) Cultures were prepared from 10-day old tk+ and tk- mice and cultured for different 
days in vitro with or without GCV. Western blotting was performed on 10 μg protein and 
detected with (f) mouse anti-mouse PrPC IgG1 (POM1) or (g) mouse anti-GFAP IgG1 (Clone 
GA5). (h-i) Cultures were prepared as in (e) and treated with GCV for 5 weeks, including a 
positive control of tk- tissue treated with 5 μM staurosporine for 24 h and PI incorporation was 
measured (n = 12). Slices were harvested and caspase-3 enzymatic activity was measured 
and normalized to protein contents (n = 3 pools of 4 slices). (i-j) Tk+ slices were treated with 
GCV for 10 days and living tissue was incubated with IB4 (green) and PI (red). Images were 
acquired on a wide-field microscope. Open arrows indicate IB4-/PI+ cells and closed arrows 
indicate IB4+/PI+ cells. (k-l) Samples were prepared as in (e) except that after 13 DPI (days 
post inoculation) BrdU incorporation was performed and the tissue was stained with rat α-
bromodeoxyuridine IgG1 (green) and α-CD68 IgG2a (red). (k) Example of CD68+ (red) and 
BrdU+ (green) cells. Closed arrows represent CD68+/BrdU+ cells and open arrows represent 
BrdU+/CD68- cells. (l) CD68+/BrdU+ and CD68-/BrdU+ cells were counted (n = 6, each the 
average of 5 individual 40X images). Data points represent the averages of n replicas ± 
standard deviation (SD). 
 
Figure 5: Impact of microglia depletion on prion replication. Cultures were prepared from 10-
day old tga20TK or Prnpo/o mice either CD11b-HSVTK+ (tga20TK+ or Prnpo/o/TK+) or CD11b-
HSVTK- (tga20TK-) mice. (a) After treatment with RML (2.7 log SCI50), tga20TK- and tga20TK+ 
slices were separated into 2 pools each and 1 insert out of each pool were treated with GCV. 
(a) Western blotting of samples digested with PK, detected with mouse anti-mouse PrPC IgG1 
(POM1). (b) Cultures prepared from 10-day old GFAP-HSVTK- (gfapTK-), GFAP-HSVTK+ 
(gfapTK+) or Prnpo/o mice were treated and analyzed as in (a). (c-h) Macrophage-
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reconstitution of microglia-depleted tissue. (c) Experiment performed as in (a). GCV-
treatment of RML-infected tga20TK+ slices led to a dramatic increase in PrPSc accumulation 
(lane 6-7), which was partially rescued by reconstitution with Prnpo/o and tga20+/+ 
macrophages (lane 8-9) showing that the effects observed by microglia depletion were 
macrophage specific. (d) Undigested sample detected with POM1, (e) rabbit anti-human Iba1 
(* indicate an unknown protein cross reacting with the Iba1 antibody as described by the 
supplier) or (f) mouse anti-GFAP IgG1 (Clone GA5). (g) Caspase-3 enzymatic activity was 
measured and normalized to protein contents. Data is presented as the average of 4 
biological replicas ± standard deviation (SD), (n.s. = p>0.05). (h) Homogenates of tga20TK+ or 
Prnpo/o/TK+ slices infected with RML (2.7 log SCI50) for 5 weeks either in the absence (-GCV) 
or presence of GCV (+GCV) were transmitted into the scrapie cell assay in endpoint format 
(SCEPA). 3 independent biological replicas of tga20TK+ and single replicas of Prnpo/o/TK+ 
slices or RML were analyzed in 10-fold dilution steps from 100 μg/ml – 1 ng/ml using 6-12 
replica wells per dilution (300 μl/well). Infected slices prepared from the same animal (pairs 
of -GCV and +GCV samples) are represented by identical color codes. TCI: Tissue culture 
infectivity. (i) Cultures were prepared from 10-day old tga20TK+ or Prnpo/o/TK+ mice and treated 
with RML in 10-fold dilution steps from 1.7 to -1.3 log SCI50. Each sample was divided in two 
pools. One pool was treated with GCV and one pool was left untreated. The tissue was 
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Supplementary Figure 1: Viability and morphology of organotypic cerebellar tissue cultures. 
(a) PI retention in whole-mounted cerebellar slices. Native slices were mostly PI-negative 
even after 35 days of culture, whereas staurosporine induced PI retention in a large fraction 
of cells. Owing to its high cellularity, the granule cell layer is prominently stained. (b) PI 
incorporation (n = 12) and caspase-3 activity in staurosporine-treated slices (3 pools of 4 
slices). Untreated samples show less than 2% PI-incorporation and caspase activity of 
staurosporine-treated samples, showing that the tissue is viable. (c) Impact of prion infection 
on slice tissue morphological integrity over time. Tga20TK and Prnpo/o cultures were 
inoculated with 100 μg RML or Ø. 1, 7, 21 or 35 days post inoculation, the tissue was fixed in 
2% PFA and stained with (c) α-Calbindin IgG1, (d) rat α-MBP IgG2a, (e) rabbit α-GFAP 
polyclonal antibody, (f) IB4-Alexa488 or (g) rat α-CD68 IgG2a. Neurons (calbindin), astrocytes 
(GFAP) and myelin (MBP) appeared intact. However a broadening of the different cell layers 
were evident at later time points, especially for the purkinje layer (c). Isolectin-B4 (IB4) and 
CD68+ microglia/macrophages increased over time confirming that preparing the slices 
induces microgliosis (also see Fig. 4c-d, k-l). No difference was detected between RML-
treated Prnpo/o, RML-treated tga20TK or mock-treated tga20TK cultures at any given time point 
(c-f), data not shown). 
 
Supplementary Figure 2: Determination of optimal PK concentration for PrPSc detection in 
slices. Slices were cultured for 5 weeks, lysates (20 or 80 μg) were blotted after PK digestion 
(25-100 μg/ml), and PrP was detected with antibody POM1. Undigested PrPC was observed 
when 80 μg protein lysate was digested with 20 μg/ml PK (lane 11), but not when 20 μg 
protein lysate was digested with 20 μg/ml PK. Therefore 20 μg/ml PK represents the minimal 
PK-concentration needed to fully digest PrPC in tga20TK slices.   
 
Supplementary Figure 3: Slice cultures of prion-inoculated mice. 3-day old tga20 or Prnpo/o 
pups were inoculated with 30 μg RML (3 μl, 1% brain homogenate) injected into the 
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cerebellum. Cerebellar slices were prepared from 12-day old tga20 mice (9 days post 
inoculation) and kept 35 days in vitro. Samples were analyzed by Western blotting. Abundant 
PK-resistant material was found in brain homogenates from a terminal scrapie-sick C57BL/6 
mouse (lane 2-3). No PK-resistant material was observed in slices prepared from RML-
treated tga20 mice (lane 8-15, n=4) or RML-treated Prnpo/o mice (lane 4-7), indicating that 
the tissue was not prion-infected.  
 
Supplementary Figure 4: Sensitivity of western blot detection of PrPSc. Tga20TK cultures 
were inoculated with 1 μg RML and after 35 DIV PrPSc levels were compared by PrPC 
Western blotting to a dilution curve of RML diluted in uninfected brain homogenate. The total 
amount of protein recovered from the RML-infected slices was 400 μg, of which only 20 μg 
(5%) were loaded onto the blot (lane 10). In the unlikely event that 100% of the inoculum 
used to infect the cultures (1 μg) was recovered 5 weeks post inoculation; maximally 50 ng 
(5%) of inoculum could have been loaded onto the blot. The PrPSc band intensity for the RML 
infected sample (containing at most 50 ng RML) corresponded to the band intensity of a 
dilution containing 2000 ng RML (lane 5 compared to lane 10). Since we detect 40 times 
more PrPSc than what we initially treated the tissue with, we conclude that an amplification of 
PrPSc has taken place. Legend for the RML-treated tga20TK sample indicates the maximal 
amount of input inoculum that theoretically could be recovered.  
 
Supplementary Figure 5: Expression of PrPC in POSCA slices. (a): non-digested samples 
from the experiment depicted in Fig. 1b. Tga20TK and Prnpo/o slices were inoculated with 
various concentrations of RML or noninfectious brain homogenate, and cultured for 35 days. 
No differences in PrPC expression were seen in the prion infected tga20TK samples and no 
residual inoculum was observed in any of the Prnpo/o samples. (b): Non-digested samples 
from Fig. 1c. Cultures from tga20TK (+) and Prnpo/o (-) pups were inoculated with 100 μg Ø or 
RML and harvested after 1 h, or after 7, 21 or 35 days. (c) Non-digested samples from Fig. 
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1d. Tga20TK, tga20+, Prnp+/o or Prnpo/o slices were inoculated with 1 mg RML (R) or 
uninfected brain homogenate (Ø), and harvested at 35 dpi.. 
 
Supplementary Figure 6: Determination of ID50. Tga20TK and Prnpo/o cultures were 
inoculated with 100 μg of scrapie strain 87V, 100 μg, 1 μg (n = 4) or 0.1 μg (n = 4) of RML 
and cultured for 35 days in vitro. Western blotting was performed on (+) samples digested 
with PK or (-) undigested samples. PrPSc was observed in all tga20TK samples treated with 1 
μg or more RML and in none of the samples treated with 0.1 μg RML.  
 
Supplementary figure 7: Cultures were prepared from 10-day old CD11b-HSVTK+ (tk+) and 
CD11b-HSVTK- (tk-) mice and cultured for 14 days with or without GCV. Slices were 
reconstituted with 250,000 macrophages either by adding macrophages directly onto the 
tissue (+Ф) or separated by a membrane (sep.). A small increase was observed in microglia 
depleted tissue and this increase could be partially rescued by reconstituting the tissue with 
macrophages. No effect was observed when the macrophages were cultured physically 
separated from the tissue. PI incorporation was measured (One-way ANOVA with 
Bonferroni’s multiple comparison test, p<0.001, n = 12). Data is presented as the average of 
n replicas ± standard deviation (SD). 
 
Supplementary Figure 8: Expression of PrPC in POSCA slices. (a) Non-digested samples 
from Fig. 5a. Cultures were prepared from 10-day old tga20TK or Prnpo/o mice either CD11b-
HSVTK+ (tga20TK+ or Prnpo/o/TK+) or CD11b-HSVTK- (tga20TK-) mice. After treatment with RML 
(2.7 log SCI50), tga20TK- and tga20TK+ slices were separated into 2 pools each and 1 insert 
out of each pool were treated with GCV. No difference were observed in the expression of 
PrPC. (b) Non-digested samples from Fig. 5b. Cultures were prepared from 10-day old 
GFAP-HSVTK- (gfapTK-), GFAP-HSVTK+ (gfapTK+) or Prnpo/o mice and treated as in (a). No 
major differences were observed in the expression of PrPC. (c) Non-digested samples from 
Fig. 5i. Cultures were prepared from 10-day old tga20TK+ or Prnpo/o/TK+ mice and treated with 
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RML in 10 fold dilution steps from 1.7 to -1.3 log SCI50. Each samples was divided in two 
pools. One pool was treated with GCV and one pool was left untreated. The tissue was 
harvested 35 days post inoculation. No major differences were observed in the expression of 
PrPC.  
 
Supplementary Video 1: Video microscopy of microglia depletion. Slices prepared from 
CD11b-HSVTK mice were treated with GCV for 8 days and IB4 was added to the cell culture 
medium. Images were recorded on a wide-field fluorescent microscope every 30 minutes for 
5 days and the video is shown at a rate of 10 frames/s. 
 
Supplementary Table 1: Strain overview (POSCA replication relative to incubation times). 
Original inocula were derived from scrapie-affected sheep, BSE-affected cows, and CWD-
affected deer. The number of mouse passages of the inoculum (more than 4 passages (>4) 
are considered fully adapted) and the genotype of the last mouse the inoculum was 
passaged in are indicated. The average time until terminal disease (± SD) for the mice that 
was used to generate the inoculum is indicated. Furthermore, the approximate intensity of 
PrPSc western blot signal 5 weeks post inoculation in tga20 slices treated with 100 μg/ml 
inoculum, is indicated. No replication is indicated as (-), weak replication as (+), intermediate 
replication as (++), and strong replication as (+++).  
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5193/1 tga20 (2) 138* +
RML6 CD-1 (>4) 141 ± 8 +++
79A C57BL/6 (>4) 159 ± 3 +++
139A C57BL/6 (>4) 159 ± 2 +++
ME7 129/Sv (>4) 180* +
5192/2 C57BL/6 (2) 270* +
22F C57BL/6 (>4) 282 ± 8 -
301V C57BL/6 (>4) 287 ± 22 -
87A C57BL/6 (>4) 358 ± 12 -
87V C57BL/6 (>4) 635 ± 0** -
B
SE 301C C57BL/6 184 ± 8 ++
5194 tga20 (4) 138* -
5005 tga20 (2) 228* -
5002 tga20 (1) 400* -
*Inoculum was generated from a single mouse 








***No replication (-), weak replication (+), intermediate replication (++), strong replication (+++)  
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Supplementary Figure 1: Viability and morphology of organotypic cerebellar tissue cultures. 
PI retention in whole-mounted cerebellar slices. Native slices were mostly PI-negative even after 35 days 
in culture (a), whereas staurosporine induced PI retention in a large fraction of cells (b-c) PI incorporation 
(n = 12) and caspase-3 activity in staurosporine-treated slices (3 pools of 4 slices). Untreated samples 
show less than 2% PI-incorporation and caspase activity of staurosporine-treated samples, showing that 





 cultures were inoculated with 100 μg RML or Ø. 1, 7, 21 or 35 days post inoculation, 
the tissue was fixed in 2% PFA and stained with (d) α-Calbindin IgG1, (e) rat α-MBP IgG2a, (f) rabbit α-
GFAP polyclonal antibody, (g) IB4-Alexa
488
 or (h) rat α-CD68 IgG2a. Neurons (calbindin), astrocytes 
(GFAP) and myelin (MBP) appeared intact. However a broadening of the different cell layers were 
evident at later time points, especially within the Purkinje layer (c). Isolectin-B4 (IB4) and CD68
+
 
microglia/macrophages increased over time confirming that preparing the slices induces microgliosis (also 







 cultures at any given time point (d-f), data not shown). 
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A versatile prion replication assay in organotypic slices
Falsig, J., Julius, C., Margalith, I., Schwarz, P., Heppner, F.L. & Aguzzi, A.
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Supplementary Figure 2: Determination of optimal PK concentration for PrP
Sc
 detection in slices. 
(a) Slices were cultured for 5 weeks, lysates (20 or 80 μg) were blotted after PK digestion (25–100 
μg ml
–1
), and PrP was detected with antibody POM1. Undigested PrP
C
 was observed when 80 μg 
protein lysate was digested with 20 μg ml
–1
 PK (lane 11), but not when 20 μg protein lysate was 
digested with 20 μg ml
–1 
PK. Therefore 20 μg ml
–1 
PK represents the minimal PK-concentration 




 slices. (b) Slice cultures of prion-inoculated mice. 3-day old 
tga20 or Prnp
o/o
 pups were inoculated with 30 μg RML (3 μl, 1% brain homogenate) injected into 
the cerebellum. Cerebellar slices were prepared from 12-day old tga20 mice (9 days post 
inoculation) and kept 35 days in vitro. Samples were analyzed by Western blotting. Abundant PK-
resistant material was found in brain homogenates from a terminal scrapie-sick C57BL/6 mouse 
(lane 2–3). No PK-resistant material was observed in slices prepared from RML-treated tga20 mice 
(lane 8–15, n=4) or RML-treated Prnp
o/o
 mice (lane 4–7), indicating that the tissue was not prion-
infected. This outcome is consistent with multiple reports that prions undergo a long period of 
eclipse after intracerebral challenge, during which no infectivity can be recovered from the site of 
inoculation. We conclude that prion infection before explanting the tissues is not an efficient way to 
achieve prion replication in culture. 
PK:  +  +   +   +   +   +  +   +   –      –                  
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Supplementary figure–3 (Falsig)




 cultures were 
inoculated with 1 μg RML and after 35 DIV PrP
Sc
 levels were compared by PrP
C
 Western blotting 
to a dilution curve of RML diluted in uninfected brain homogenate. The total amount of protein 
recovered from the RML-infected slices was 400 μg, of which only 20 μg (5%) were loaded onto 
the blot (lane 10). In the unlikely event that 100% of the inoculum used to infect the cultures (1 
μg) was recovered 5 weeks post inoculation; maximally 50 ng (5%) of inoculum could have been 
loaded onto the blot. The PrP
Sc
 band intensity for the RML infected sample (containing at most 50 
ng RML) corresponded to the band intensity of a dilution containing 2000 ng RML (lane 5 
compared to lane 10). Since we detect 40 times more PrP
Sc
 than what we initially treated the tissue 
with, we conclude that an amplification of PrP
Sc
 has taken place. Legend for the RML-treated 
tga20
TK 
sample indicates the maximal amount of input inoculum that theoretically could be 
recovered. 
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Supplementary Figure 4: Expression of PrP
C
 in POSCA slices. (a): non-digested samples from 




 slices were inoculated with various 
concentrations of RML or noninfectious brain homogenate, and cultured for 35 days. No 
differences in PrP
C
 expression were seen in the prion infected tga20
TK
 samples and no residual 
inoculum was observed in any of the Prnp
o/o
 samples. (b): Non-digested samples from Fig. 1c. 
Cultures from tga20
TK
 (+) and Prnp
o/o
 (–) pups were inoculated with 100 μg Ø or RML and 









 slices were inoculated with 1 mg RML (R) or uninfected brain 
homogenate (Ø), and harvested at 35 dpi. 
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 cultures were inoculated with 100 μg of scrapie strain 87V, 100 μg, 1 μg (n = 4) or 0.1 
μg (n = 4) of RML and cultured for 35 days in vitro. Western blotting was performed on (+) 
samples digested with PK or (–) undigested samples. PrP
Sc
 was observed in all tga20
TK
 samples 
treated with 1 μg or more RML and in none of the samples treated with 0.1 μg RML. (b) 
Transmission of murine-adapted BSE and scrapie strains. Cultures were prepared from 10-day old 
tga20
+/+
 (++++) and Prnp
o/o
 (o/o) pups, inoculated with various prion strains (100 μg), and 
harvested after 35 days. Ø: noninfectious brain homogenate. For comparison, RML-infected slice 
culture samples were diluted 10-fold in uninfected brain homogenate prior to PK-digestion (lane 
10). Western blotting was performed under less stringent conditions on 30 μg protein digested 
with 25 μg ml
–1
 PK (+) or 10 μg non-digested protein (–) and detected with POM1. Abundant 
PrP
Sc
 was observed in tga20 slices infected with RML and the BSE strain 301C and a very weak 
PrP
Sc
 signal could be seen in slices treated with the scrapie strains 5193/1 and 5192/2. The two 
later strains did show all three PrP
Sc
 associated bands when analyzed under more sensitive 













































) mice and cultured for 14 days with or without GCV. Slices were 
reconstituted with 250,000 macrophages either by adding macrophages directly onto the tissue 
(+Ф) or separated by a membrane (sep.). A small increase was observed in microglia depleted 
tissue and this increase could be partially rescued by reconstituting the tissue with macrophages. 
No effect was observed when the macrophages were cultured physically separated from the tissue. 
PI incorporation was measured (One-way ANOVA with Bonferroni’s multiple comparison test, 
P<0.001, n = 12). Data is presented as the average of n replicas ± standard deviation (SD). 
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Supplementary Figure 7: Expression of PrP
C
 in POSCA slices. (a) Non-digested samples from 




















 slices were separated into 2 pools each and 1 insert out of each pool 
were treated with GCV. No differences were observed in the expression of PrP
C
. (b) Non-digested 











 mice and treated as in (a). No major differences were observed in the 
expression of PrP
C





 mice and treated with RML in 10 fold dilution steps from 1.7 to –1.3 log 
SCI50. Each samples was divided in two pools. One pool was treated with GCV and one pool was 
left untreated. The tissue was harvested 35 days post inoculation. No major differences were 

















Sheep scrapie 5193/1 Tga20 2 138* + 
 RML6 CD1 >4 141±8 +++ 
 79A C57BL/6 >4 159±3 +++ 
 139A C57BL/6 >4 159±2 +++ 
 ME7 129/Sv >4 180* + 
 5192/2 C57BL/6 2 270* + 
 5114/2 Tga20 1 414 + 
 22F C57BL/6 >4 282±8 – 
 301V C57BL/6 >4 287±22 – 
 87A C57BL/6 >4 358±12 – 
 87V C57BL/6 >4 635±0** – 
Cow BSE 301C C57BL/6 >4 184±8 ++ 
Deer CWD 5194 Tga20 4 138* – 
 5005 Tga20 2 228* – 
 5002 Tga20 1 400* – 
      
      
Supplementary Table 1. Synopsis of the various prion strains used for infection of POSCA 
slices. Original inocula were derived from scrapie-affected sheep, BSE-affected cows, and 
CWD-affected deer. The columns display the number of mouse passages undergone by the 
inoculum (>4 passages are considered fully adapted), the genotype of the mice in which the 
inoculum was last passaged, and the average time until terminal disease (± SD) in the mice 
used to generate the inoculum.  
* Inoculum was generated from a single mouse 
** Only 3 out of 4 mice came down with scrapie 
*** No replication (–), weak replication (+), intermediate replication (++), strong replication 
(+++) as estimated by the approximate intensity of PrPSc western blot signals. 
Supplementary Table–1 (Falsig)
